Details for Patent: 12,083,270
Which drugs does patent 12,083,270 protect, and when does it expire?
Patent 12,083,270 protects XHANCE and is included in one NDA.
This patent has nineteen patent family members in seven countries.
Summary for Patent: 12,083,270
| Title: | Delivery device and method |
| Abstract: | A nasal delivery device for and method of delivering substance to the middle meatus in a nasal cavity of a subject in the treatment of a condition, in particular an inflammatory or infectious condition, thereof, the delivery device comprising: a nosepiece unit (17) including a nosepiece (20) for fitting to a nostril of a subject and a nozzle (25) through which substance is in use delivered to the respective nasal cavity; and a delivery unit (29) for delivering substance through the nozzle of the nosepiece; wherein the delivery device is configured to provide for deposition of a significant fraction of the delivered dose on, around and in the vicinity of the middle meatus. |
| Inventor(s): | Per Gisle Djupesland, Roderick Peter Hafner, Colin David Sheldrake |
| Assignee: | Optinose Inc |
| Application Number: | US12/279,285 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 12,083,270
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paratek Pharms | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | 12,083,270 | ⤷ Start Trial | METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,083,270
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2007216287 | ⤷ Start Trial | |||
| Australia | 2014210670 | ⤷ Start Trial | |||
| Australia | 2016204847 | ⤷ Start Trial | |||
| Australia | 2018203724 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
